Combination of Zizyphus jujuba and Green Tea Extracts Exerts Excellent Cytotoxic Activity in HepG2 Cells via Reducing the Expression of APRIL
- 1 January 2009
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 37 (01), 169-179
- https://doi.org/10.1142/s0192415x09006758
Abstract
Hepatocellular carcinoma is a type of tumor highly resistant to available chemotherapeutic agents. The treatment of hepatocellular carcinoma remains a challenge that needs new approaches in the future. In a previous study, we demonstrated that the chloroform fraction (CHCl3-F) from Z. jujuba has anticancer activity in human liver cancer cells (HepG2), and that combining CHCl3-F with green tea extracts (GTE) results in enhanced effects of anticancer activity in the cells. To further understand the mechanism of the anticancer activity of combining CHCl3-F and GTE in HepG2 cells, we investigated whether the addition of a mixture of CHCl3-F and GTE would affect the expression of APRIL (a proliferation-inducing ligand), which was expressed in HepG2 cells from 4 hours of incubation in vitro. We have shown that CHCl3-F and GTE enhanced anti-cancer activity by reducing the expression of APRIL. We speculate that the CHCl3-F and GTE mixture might provide a lead to a new drug design to treat hepatocellular carcinoma in the future.Keywords
This publication has 27 references indexed in Scilit:
- Hepatocellular Carcinoma: Molecular Biology and TherapySeminars in Oncology, 2006
- Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: A critical appraisalLiver Transplantation, 2006
- Viral hepatitis and liver cancer: the case of hepatitis COncogene, 2006
- Role of BAFF and APRIL in human B‐cell chronic lymphocytic leukaemiaImmunology, 2006
- Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1αBlood, 2005
- Future perspectives for hepatocellular carcinomaHPB, 2003
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- The therapeutic potential of flavonoidsExpert Opinion on Investigational Drugs, 2000
- Tumor-suppressor p53 and the cell cycleCurrent Opinion in Genetics & Development, 1993
- An evaluation of three In vitro cytotoxicity assaysFood and Chemical Toxicology, 1986